Oral sufentanil

Phase 2

Phase 2

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

No catalyst events have been recorded for this drug yet.

Competitive Landscape

0 competitors in Major Upper or Lower Abdominal Surgery

Drug Information

Target Indication

Major Upper or Lower Abdominal Surgery

Clinical Trial

Last updated: 2/13/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science

Mechanism of action & safety profile

Developer

TLPH

TALPHERA, INC.

Related Pipeline

Moderate-to-severe Acute Pain

Pain, Postoperative

Moderate-to-severe Acute Pain

Post-Operative Pain

Post-Operative Pain

Get Catalyst Alerts

Receive weekly digests of upcoming catalysts